Vertical: CNMBase Year: 2025
Market Size (2025)
$200.59M
Projected (2032)
$284.57M
CAGR (2022–2032)
5.1%
Key Players
9+
Market Overview
The global algae-based feed ingredients market was valued at USD 200.59 Million in 2025 and is projected to reach USD 284.57 Million by 2032, registering a CAGR of 5.12% during the forecast period 2026–2032. The market has expanded steadily from USD 172.62 Million in 2022, and the forecast period adds an absolute value of USD 83.98 Million between 2025 and 2032.
Algae-based feed ingredients comprise microalgae biomass and oils rich in long-chain omega-3 fatty acids (principally DHA and EPA), dried seaweed meal, and a range of other algae-derived ingredients such as spirulina, chlorella, seaweed extracts and red-seaweed methane inhibitors. Demand is driven by the aquaculture industry's need to reduce its dependence on fish oil and fishmeal, by the broader shift toward functional and antibiotic-free feed formulations, and by growing interest in feed-based solutions for enteric methane reduction in ruminants.
Key Findings
Product Type: Microalgae (DHA-rich) is both the largest and the fastest-growing product type, accounting for 50.0% of the market in 2025 (USD 100.29 Million) and expanding at a CAGR of 6.18% to reach USD 153.10 Million by 2032.
Livestock: Aquaculture is the largest and the fastest-growing livestock category, holding a 40.0% share in 2025 (USD 80.23 Million) and growing at a CAGR of 6.37% to USD 123.79 Million by 2032.
Region: Asia Pacific is the leading region with a 42.0% share (USD 84.25 Million) in 2025, while Middle East & Africa is the fastest-growing region at a CAGR of 7.50%.
Country: China is the leading country market at USD 38.75 Million in 2025, equivalent to 19.3% of the global market. The UAE is the fastest-growing country market at a CAGR of 8.79%, followed by Saudi Arabia (8.22%) and India (7.48%).
Growth contribution: Microalgae (DHA-rich) contributes USD 52.80 Million of the USD 83.98 Million absolute growth expected between 2025 and 2032, and Aquaculture contributes USD 43.55 Million.
Segmentation Summary
The market is analysed by product type (Microalgae (DHA-rich), Seaweed Meal and Others), by livestock (Aquaculture, Poultry and Ruminants & Others) and by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), with country-level analysis for 20 countries and sub-regions. Microalgae (DHA-rich) ingredients lead the product type segmentation because of their role as a direct replacement for fish oil in salmon, shrimp and marine fish feeds. Seaweed Meal holds 30.0% of the market (USD 60.18 Million) and grows at a CAGR of 4.20%, while Others accounts for 20.0% (USD 40.12 Million) with a CAGR of 3.63%. By livestock, Ruminants & Others is the second-largest category at 35.0% (USD 70.21 Million) but grows at the slowest rate (3.12%), while Poultry holds 25.0% (USD 50.15 Million) and grows at 5.65%.
Competitive Landscape Summary
The competitive landscape is concentrated in the microalgae DHA segment, where a small number of producers operate industrial-scale heterotrophic fermentation capacity. Veramaris, the joint venture of dsm-firmenich and Evonik, and Corbion (AlgaPrime DHA) are the principal suppliers of algal omega-3 oils and biomass to aquafeed producers. The seaweed meal and other algae ingredient segments are more fragmented and are served by vertically integrated seaweed harvesters and processors such as Acadian Seaplants, by marine-algae feed additive specialists such as Olmix Group, and by smaller producers such as Allmicroalgae and CH4 Global. Recent strategic activity includes the acquisition of Olmix by EW Group (completed in August 2026), dsm-firmenich's agreement to divest its Animal Nutrition & Health business to CVC Capital Partners while retaining its stake in Veramaris, Corbion's investment decision to debottleneck omega-3 DHA oil capacity, and CH4 Global's distribution partnerships with UPL and Mitsubishi Corporation.
Challenges and Opportunities
The principal challenge for the market is cost competitiveness. Algal oils and biomass compete directly with fish oil, fishmeal and vegetable oils, and periods of lower fish oil prices put pressure on algal omega-3 pricing, as reported by Corbion in its 2026 interim results. Scale-up of fermentation and seaweed cultivation capacity requires significant capital, and new ingredients such as methane-reducing red seaweed face lengthy regulatory approval processes and questions regarding consistency and residues. Seaweed meal quality is also affected by variability in iodine and heavy-metal content.
Opportunities are concentrated in aquaculture expansion in Asia Pacific and Latin America, in the premium pet food segment, where suppliers have launched dedicated algal omega-3 products, and in ruminant methane reduction, where algae-based supplements address emerging climate commitments. Government programmes supporting seaweed cultivation, such as the EU Algae Initiative and India's Pradhan Mantri Matsya Sampada Yojana (PMMSY), are expected to improve the supply base for seaweed-derived feed ingredients.
Future Outlook
The market is expected to grow by USD 83.98 Million between 2025 and 2032. Microalgae (DHA-rich) is projected to increase its share from 50.0% in 2025 to 53.8% in 2032, and Aquaculture from 40.0% to 43.5%. Asia Pacific will remain the largest regional market, reaching USD 124.07 Million by 2032, while Latin America (6.41%) and Middle East & Africa (7.50%) are projected to grow faster than the global average. Europe (3.87%) and North America (4.39%) are expected to grow more slowly, reflecting their more mature feed markets. The U.S. remains the second-largest country market, accounting for 16.4% of global value in 2025.
The Algae-Based Feed Ingredients Market market is projected to grow at a CAGR of 5.1% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Algae-based feed ingredients are feed materials and feed additives derived from microalgae (single-celled photosynthetic or heterotrophic organisms, including cyanobacteria such as spirulina) and macroalgae (seaweeds) that are incorporated into compound feeds, premixes, supplements or on-farm rations for farmed animals. They are supplied as whole dried biomass, oil, meal, paste, suspension or extract, and are used to provide essential nutrients (such as the long-chain omega-3 fatty acids DHA and EPA, proteins, minerals and pigments) or to deliver functional effects such as gut health support, immune modulation and enteric methane reduction.
The scope of this study includes the following:
Microalgae (DHA-rich): whole-cell biomass and oils produced from DHA- and EPA-rich microalgae strains (for example, Schizochytrium) by heterotrophic fermentation or phototrophic cultivation, used primarily as fish oil replacements.
Seaweed Meal: dried and milled macroalgae (for example, Ascophyllum nodosum and other brown, red and green seaweeds) used as a source of minerals, polysaccharides and bioactive compounds.
Others: other algae-derived feed ingredients, including spirulina and chlorella biomass, seaweed extracts and polysaccharide-based additives, and red-seaweed (Asparagopsis) products for methane reduction in ruminants.
The study excludes algae products used in human food and dietary supplements, cosmetics, plant biostimulants and fertilisers, and biofuels, as well as algae-derived hydrocolloids (such as agar, carrageenan and alginates) sold for food and industrial uses. Fish oil, fishmeal, synthetic omega-3 products and other non-algal feed ingredients are also excluded.
Research Objectives
To estimate the size of the global algae-based feed ingredients market in value terms (USD Million) for the historic period 2022–2024 and the base year 2025, and to forecast it for 2026–2032.
To analyse the market by product type (Microalgae (DHA-rich), Seaweed Meal and Others) and identify the factors behind the growth of each segment.
To analyse the market by livestock (Aquaculture, Poultry and Ruminants & Others) and assess the adoption of algae-based ingredients in each animal category.
To assess the market across five regions and 20 countries and sub-regions, identifying the leading and fastest-growing geographies.
To evaluate the drivers, restraints, opportunities, trends and challenges affecting the market, including fish oil supply conditions, aquaculture growth and livestock methane reduction.
To analyse the value chain, competitive forces, regulatory landscape and macro-environmental (PESTEL) factors influencing the market.
To profile the competitive landscape, including the positioning of key players and their strategic developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured research process combining secondary research, primary research and analytical modelling. The process begins with defining the market scope and segmentation, followed by collection of data from secondary sources to build an initial understanding of the market, its value chain and its participants. Primary research is then used to validate and refine the secondary findings. Market size estimates are developed using both top-down and bottom-up approaches, triangulated to arrive at final values, and projected over the forecast period using a factor-based forecasting model.
Step 1: Definition of the market, product scope and segmentation.
Step 2: Secondary research to collect market, industry and company data.
Step 3: Primary research with supply-side and demand-side participants.
Step 4: Market size estimation using top-down and bottom-up approaches.
Step 5: Data triangulation and validation.
Step 6: Forecasting and final review of the market model.
Secondary Research
Secondary research formed the foundation of the study and covered the following types of sources relevant to the algae and animal feed industries:
Industry associations: aquaculture, feed and algae industry bodies such as the International Feed Industry Federation, the European Feed Manufacturers' Federation (FEFAC), the Global Seafood Alliance and the European Algae Biomass Association.
Government and regulatory bodies: the Food and Agriculture Organization of the United Nations (FAO), the European Food Safety Authority (EFSA), the European Commission, the U.S. Food and Drug Administration (FDA), the U.S. Department of Agriculture (USDA), NOAA Fisheries, the Canadian Food Inspection Agency (CFIA) and national fisheries and agriculture ministries.
Company filings: annual reports, financial statements, investor presentations and press releases of algae ingredient producers, feed additive companies and aquafeed manufacturers.
Trade journals and publications: industry publications covering animal feed and aquaculture, and peer-reviewed scientific literature on algae nutrition and feed trials.
Paid databases: trade statistics, company databases and commodity price databases covering fish oil, fishmeal and feed raw materials.
Primary Research
Primary research was conducted through in-depth interviews with industry participants across the value chain. The objectives were to validate market size estimates and segment splits, to understand pricing, adoption rates and inclusion levels by livestock category, and to obtain qualitative insight into demand drivers, regulatory developments and competitive dynamics.
Supply side: executives, product managers and technical specialists at microalgae and seaweed ingredient producers, feed additive manufacturers, distributors and fermentation technology providers.
Demand side: procurement managers and nutritionists at aquafeed and compound feed manufacturers, integrated poultry and aquaculture producers, and livestock and dairy operations.
Other participants: academic researchers, industry consultants and representatives of industry associations.
Market Size Estimation
Top-down approach: The overall size of the animal feed and feed ingredient market was used as the starting point. The share attributable to algae-based ingredients was derived using data on omega-3 ingredient demand in aquafeed, seaweed meal consumption and the penetration of algae-based additives in each livestock category, and then split by product type, livestock and geography.
Bottom-up approach: Revenues of key algae ingredient producers from their feed-related business, estimated production capacities, and volumes consumed by end-use segment were aggregated and multiplied by average selling prices by product type and region to arrive at the market value.
Data triangulation: The results of the two approaches were compared and reconciled. Differences were resolved through additional secondary research and validation with primary respondents, ensuring that segment, regional and country values are internally consistent and sum to the overall market total.
Forecasting Methodology
Forecasts were developed using a factor-based model that links market growth to its underlying demand and supply drivers. The factors considered include:
Growth in aquaculture, poultry and ruminant production by region and country.
Fish oil and fishmeal supply conditions and price trends.
Production capacity additions and cost trends for microalgae fermentation and seaweed cultivation.
Regulatory developments, including approvals of new algae ingredients and antimicrobial-use restrictions.
Sustainability and climate commitments, including livestock methane reduction targets.
Macroeconomic indicators, including GDP growth, population and per capita protein consumption.
Historic trends for 2022–2024 and the base year 2025 were used to calibrate the model, and growth rates were applied by segment and geography for each year of the forecast period. The resulting forecasts were reviewed with industry participants.
Base Year, Forecast Period and Currency
Base year: 2025
Historic years: 2022, 2023 and 2024
Forecast period: 2026–2032
CAGR period: 2026–2032
Currency: USD Million (nominal values)
Assumptions and Limitations
Market values are expressed in nominal U.S. dollars; the effects of currency fluctuations are not modelled separately.
The forecast assumes no major disruption to global feed supply chains beyond normal cyclical variation in fish oil and agricultural commodity prices.
Regulatory frameworks for feed ingredients in the major markets are assumed to evolve gradually, without abrupt restrictions on approved algae ingredients.
Many algae ingredient suppliers are private or do not report feed-related revenues separately, so company-level revenues were estimated where segment disclosures are not available.
Country-level estimates for smaller markets and for the Rest of Europe, Rest of Asia Pacific, Rest of Latin America and Rest of MEA groupings are subject to wider margins of estimation owing to limited published data.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The algae-based feed ingredients market has a mixed structure. The Microalgae (DHA-rich) segment is relatively consolidated, because industrial-scale production of algal omega-3 depends on proprietary strains, large fermentation assets and regulatory approvals that only a few companies hold. Veramaris, the joint venture of dsm-firmenich and Evonik, and Corbion are the leading suppliers of algal omega-3 to the aquafeed industry. The Seaweed Meal and Others segments are fragmented, with vertically integrated seaweed companies, feed additive specialists and a large number of regional harvesters, processors and start-ups.
Competition is based on product efficacy, nutritional content and consistency, price relative to fish oil and other conventional ingredients, security of supply, regulatory approvals and certifications, and technical support for feed formulation. Companies are pursuing capacity expansion, partnerships with feed producers and distributors, entry into new geographies and applications such as pet food, and acquisitions. The wider animal nutrition industry is also consolidating, which is changing ownership of several market participants.
Key Player Positioning
Leaders: Veramaris (with its parent companies dsm-firmenich and Evonik) and Corbion lead the microalgae omega-3 segment with commercial-scale fermentation capacity in the United States and Brazil respectively, established supply relationships with major aquafeed producers, and regulatory approvals in key markets. Acadian Seaplants and Olmix Group are leading suppliers of seaweed-based feed ingredients and additives, with vertically integrated seaweed supply chains and international distribution.
Challengers: Alltech offers dried microalgae fermentation products within a broad animal nutrition portfolio and has a global distribution network, although its algae production was scaled back after the closure of its Kentucky algae facility in 2018. dsm-firmenich and Evonik also participate as diversified nutrition and specialty chemicals companies whose algae feed exposure is held through Veramaris.
Niche players: CH4 Global focuses on Asparagopsis-based methane-reducing supplements for cattle and is building production capacity in South Australia, while Allmicroalgae supplies a range of microalgae species, such as Nannochloropsis and Chlorella, for aquaculture and animal feed from its facilities in Portugal.
dsm-firmenich agreed in February 2026 to divest its Animal Nutrition & Health business to CVC Capital Partners, with closing expected at the end of 2026, while retaining its 50% stake in Veramaris and integrating it into its consumer-focused nutrition and health portfolio. Evonik is pursuing a cost and portfolio simplification programme, with its algae exposure held through Veramaris. Corbion is broadening the use of AlgaPrime DHA from aquaculture into pet food and new markets such as China, and is adding omega-3 capacity by debottlenecking its existing plant. Olmix Group, acquired by EW Group in August 2026, continues to operate as a standalone company focused on marine-algae-based feed additives. Acadian Seaplants is investing in processing capacity and seaweed cultivation research, while CH4 Global is scaling pond-based Asparagopsis production and expanding internationally through distribution partners.
Competitor Dashboard
The dashboard below rates the profiled companies on four parameters relevant to their position in the algae-based feed ingredients market.
Threat of New Entrants: Medium
Industrial microalgae fermentation requires high capital investment, proprietary strains and process know-how, which creates high entry barriers in the Microalgae (DHA-rich) segment.
Entry barriers in seaweed meal are lower, and many regional harvesters and processors serve local feed markets.
Feed ingredient approvals in each market add time and cost for new entrants.
Bargaining Power of Suppliers: Medium
Fermentation feedstocks such as sugar and corn dextrose are widely available commodities, limiting supplier power.
Wild seaweed harvesting is subject to resource limits, seasonal variation and licensing, which gives holders of harvesting rights some leverage.
Specialised fermentation equipment and contract manufacturing capacity are limited.
Bargaining Power of Buyers: High
The aquafeed industry is concentrated, and large feed producers purchase significant volumes under negotiated contracts.
Buyers benchmark algal oil prices against fish oil and can adjust formulations when relative prices change.
In poultry and ruminant feed, buyers are highly price sensitive and inclusion levels are low.
Threat of Substitutes: High
Fish oil and fishmeal remain the main substitutes for microalgae omega-3 ingredients.
Vegetable oils, insect meal, single-cell proteins and other novel ingredients compete for inclusion in feed formulations.
Synthetic and non-algal feed additives, including other methane inhibitors, compete with seaweed-based products.
Competitive Rivalry: Medium
The microalgae DHA segment has few suppliers, which compete on price, product format and supply security.
The seaweed meal and other segments are more fragmented, with competition based on product efficacy, quality and regional presence.
Market growth of more than 5% per year reduces the intensity of price competition.
Threat of New Entrants: Medium; High capital and approval barriers in microalgae; lower barriers in seaweed meal.
Bargaining Power of Suppliers: Medium; Commodity feedstocks; constrained seaweed harvesting rights.
Bargaining Power of Buyers: High; Concentrated aquafeed buyers; fish oil price benchmarking.
Threat of Substitutes: High; Fish oil, vegetable oils, novel proteins and non-algal additives.
Competitive Rivalry: Medium; Few microalgae suppliers; fragmented seaweed segment; growing market.
Market estimates by geography (2032)
InsightAsia Pacific leads with $124.07M by 2032, while Middle East & Africa is projected to grow fastest at a 7.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $35.90M | $43.52M | $54.07M | 4.2% | 19% |
| Europe | $44.71M | $54.14M | $65.45M | 3.9% | 23% |
| Asia Pacific | $70.51M | $94.37M | $124.07M | 5.8% | 44% |
| Latin America | $16.57M | $22.75M | $31.02M | 6.5% | 11% |
| Middle East & Africa | $4.92M | $6.92M | $9.96M | 7.3% | 3% |
| Total | $172.62M | $221.69M | $284.57M | 5.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$284.57M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Microalgae (DHA-rich) | $153.10M | 6.4% | 54% |
| Seaweed Meal | $80.25M | 4.2% | 28% |
| Others | $51.22M | 3.2% | 18% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Algae-Based Feed Ingredients Market covering market dynamics, competitive landscape, and strategic outlook.
The Algae-Based Feed Ingredients Market market is projected to reach $284.57M by 2032, growing at 5.1% CAGR. The Microalgae (DHA-rich) segment holds the largest share.
The algae-based feed ingredients market is shaped by the interaction of supply constraints in traditional marine ingredients, the growth of aquaculture, sustainability and animal health requirements in livestock production, and the cost and scale of algae production technologies. This chapter examines the factors that promote and inhibit market growth, together with the main opportunities, trends and challenges over the forecast period.
Market Growth Factor Analysis
The table below summarises five macro factors and five micro factors that influence the market, with the type of impact each factor has and an impact score on a scale of 1 to 10 for three forecast sub-periods (2026–2027, 2028–2030 and 2031–2032). The impact scores are analyst assessments based on the secondary and primary research conducted for this study; a higher score indicates a stronger influence on market growth in the stated direction.
Constrained Fish Oil Supply and the Need for Alternative Omega-3 Sources
Fish oil has historically been the main source of the long-chain omega-3 fatty acids EPA and DHA in feeds for salmon, marine finfish and shrimp. Global fish oil output is limited by catch quotas on forage fisheries and is highly exposed to climatic events. Peru's anchoveta fishery, the largest single source of fishmeal and fish oil, had its first fishing season of 2023 cancelled because of El Niño conditions, which tightened supply and raised prices for marine ingredients. As aquafeed producers have reduced fish oil inclusion to manage cost and supply risk, EPA and DHA levels in farmed fish have declined, creating a nutritional gap that algae-derived oils can fill. Microalgae such as Schizochytrium produce DHA and EPA directly, and fermentation-based production can be scaled independently of wild fish stocks. Algal oil producers have obtained approvals and certifications that support adoption, including the first ASC-MSC algae certification for an algal omega-3 producer in 2021 and Canada's first marketing authorisation for algal oil in salmonid feed in 2024. This driver is the main reason Microalgae (DHA-rich) is both the largest and the fastest-growing product type in the market.
Continued Expansion of Aquaculture
Aquaculture is the fastest-growing source of animal protein globally. According to the FAO's State of World Fisheries and Aquaculture 2024, aquaculture production of aquatic animals exceeded capture fisheries production for the first time in 2022. Growth is concentrated in Asia Pacific, notably China, India, Vietnam and Indonesia, and in Latin America, where Chile and Ecuador are major producers of farmed salmon and shrimp respectively. Each tonne of additional farmed fish and shrimp production requires compound feed, and high-value species such as salmon, marine finfish and shrimp require omega-3 fatty acids, pigments and functional additives that can be supplied by algae. Hatchery and larval feeds also use live and processed microalgae as a primary nutrient source. The expansion of aquaculture therefore supports demand across all three product types, and explains why Aquaculture is the largest and fastest-growing livestock category in the market.
Restrictions on Antibiotics and Demand for Functional Feed Additives
Regulators and food retailers are reducing the use of antimicrobials in animal production. The European Union banned antibiotics as growth promoters in feed from 2006, and Regulation (EU) 2019/6 on veterinary medicinal products, which has applied since January 2022, further restricts the prophylactic and metaphylactic use of antimicrobials. Similar measures have been introduced in other markets, and poultry and pig integrators increasingly market products raised without antibiotics. These changes have increased demand for feed additives that support gut health, immunity and feed efficiency. Seaweed meal and seaweed extracts contain sulphated polysaccharides, polyphenols and minerals that are used in such formulations. Companies including Olmix Group and Acadian Seaplants market seaweed-based additives positioned for gut integrity, immune support and stress mitigation in poultry, swine, ruminants and aquaculture. This driver supports demand for Seaweed Meal and Others, particularly in Poultry and in Europe.
Livestock Methane Reduction and Sustainability Commitments
Enteric methane from ruminants is a significant source of agricultural greenhouse gas emissions, and governments, dairy and beef processors and retailers have adopted methane reduction targets. More than 150 countries have joined the Global Methane Pledge launched at COP26 in 2021, and California's SB 1383 sets a target to reduce methane emissions from dairy and livestock operations by 40% below 2013 levels by 2030. The red seaweed Asparagopsis contains bromoform, which inhibits methane formation in the rumen, and companies have begun commercial production of Asparagopsis-based supplements. CH4 Global made its first commercial delivery of its Methane Tamer supplement in Australia in January 2024 and opened the first phase of its Louth Bay EcoPark in South Australia in January 2025. In parallel, feed companies and seafood retailers are using algae-based ingredients to reduce the marine footprint of feeds and to meet certification requirements. These commitments are expected to strengthen demand in the Ruminants & Others category over the latter part of the forecast period.
Premium Pet Food and Specialty Animal Nutrition
Pet food manufacturers are using algal omega-3 to replace fish oil in premium products and to address sustainability concerns. Corbion launched AlgaPrime DHA P3, a microalgae powder for pet food, in September 2023, and dsm-firmenich launched Veramaris O3 Max Pure, a microalgal oil for pet food, in April 2026. Pet food offers higher price realisation than aquafeed and gives algae producers a way to diversify their customer base.
Aquaculture Growth in Emerging Markets
Aquaculture in India, Southeast Asia, Latin America, and the Middle East & Africa is expanding faster than in mature markets, supported by government programmes. Corbion's registration of AlgaPrime DHA with China's General Administration of Customs in July 2025 illustrates how suppliers are opening access to large Asian markets. Latin America (6.41% CAGR) and Middle East & Africa (7.50% CAGR) are the two fastest-growing regions in this market.
Expansion of Seaweed Cultivation
Public programmes are supporting seaweed farming. The European Commission adopted the EU Algae Initiative in November 2022 to strengthen the EU algae sector, and India's PMMSY supports seaweed cultivation along its coastline. Growth in cultivated seaweed supply is expected to improve the availability and consistency of seaweed meal and extracts for feed, and to support new products such as methane-reducing red seaweed.
High Production Costs Relative to Conventional Ingredients
Algae-based ingredients are generally more expensive than the conventional ingredients they replace. Heterotrophic fermentation of microalgae requires large stainless-steel fermentation capacity, sugar feedstock and downstream processing, while phototrophic cultivation in photobioreactors or ponds faces limitations in productivity and harvesting costs. Algal oil prices are benchmarked against fish oil, and when fish oil prices fall, algal oil suppliers face pricing pressure; Corbion reported that pricing in its Health & Nutrition segment declined in the first half of 2026 because of lower omega-3 oil prices. In price-sensitive feed markets such as poultry and ruminant feed, the higher cost of algae ingredients limits inclusion rates.
Limited Production Capacity and Long Scale-Up Timelines
Industrial-scale production of algal omega-3 is concentrated in a small number of facilities, such as the Veramaris plant in Blair, Nebraska, and Corbion's plant in Orindiúva, Brazil. Veramaris has stated that its plant can supply the equivalent of about 15% of the salmon industry's annual EPA and DHA demand. New fermentation plants require substantial investment and several years to build and commission, while seaweed cultivation at scale requires access to coastal or land-based sites and permits. Capacity constraints limit the speed at which algae ingredients can replace fish oil.
Regulatory Complexity and Raw Material Variability
New algae strains and algae-derived additives must be authorised as feed materials or feed additives in each market, and approval processes differ by jurisdiction. Seaweed raw materials can contain variable levels of iodine, arsenic and other heavy metals, which are subject to limits in feed regulations. Red-seaweed methane inhibitors raise additional questions about bromoform residues and long-term animal health effects, which slows regulatory approval and adoption.
Challenge: Demonstrating Efficacy and Cost-Benefit
Feed producers require evidence that algae ingredients deliver measurable returns, such as improved growth, health, product quality or emission reductions. Outcomes in feed trials can vary with species, inclusion level and farm conditions, and the cost of methane reduction remains a barrier where farmers are not paid for emission reductions.
Trend: Capacity Debottlenecking and Supply Chain Investment
Producers are expanding output from existing assets rather than building new plants. Corbion announced an investment decision to debottleneck its omega-3 DHA oil capacity in February 2026, and Veramaris partnered with Merwetank in September 2025 to establish bulk algal oil storage in Dordrecht, the Netherlands, to supply European aquafeed producers.
Trend: Consolidation in the Feed Additives Industry
The broader animal nutrition industry is consolidating. EW Group completed its acquisition of Olmix Group in August 2026, dsm-firmenich agreed in February 2026 to sell its Animal Nutrition & Health business to CVC Capital Partners while keeping its stake in Veramaris, and ADM and Alltech combined their North American feed businesses into a joint venture launched in February 2026. These transactions are changing the ownership of key routes to market for algae ingredients.
Trend: Certification and Traceability
Seafood buyers and retailers increasingly require certified feed ingredients. The ASC-MSC Seaweed (Algae) Standard and feed safety schemes such as GMP+ provide frameworks that algae ingredient producers use to demonstrate sustainability and safety.
The value chain of the algae-based feed ingredients market comprises four main stages, from raw material inputs to end users.
Raw Materials and Inputs
Heterotrophic microalgae production uses sugar feedstocks such as corn-derived dextrose or sugarcane, together with nutrients and proprietary microalgae strains. Phototrophic production uses light, carbon dioxide, water and nutrients. Seaweed is obtained from wild harvesting (for example, Ascophyllum nodosum in the North Atlantic) and from sea-based or land-based cultivation.
Production and Processing
Microalgae are cultivated in fermenters, photobioreactors or open ponds, then harvested, dried and, where required, processed into oil or stabilised biomass. Seaweed is cleaned, dried and milled into meal, or processed to extract polysaccharides and other bioactive compounds. Producers formulate products as powders, oils, suspensions or premix-ready additives.
Distribution and Channels
Large volumes of algal oil are sold directly to aquafeed manufacturers under supply contracts, often delivered in bulk. Seaweed meal and algae-based additives are sold through direct sales to feed mills and integrators, through premix manufacturers and through regional distributors.
End Users
End users are aquafeed and compound feed manufacturers, premix producers, integrated poultry and aquaculture companies, and livestock farmers who use algae-based supplements on farm.
Algae-based feed ingredients are regulated as feed materials or feed additives, depending on their composition and intended function. Key regulations and standards in the major regions are summarised below.
North America
United States: Animal food is regulated by the FDA under the Federal Food, Drug, and Cosmetic Act. Manufacturers must comply with the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals rule (21 CFR Part 507) under the Food Safety Modernization Act. New ingredients can be reviewed through the food additive petition process, the GRAS notification procedure for animal food, or the FDA's Animal Food Ingredient Consultation process, for which final guidance was issued in January 2025.
Canada: Livestock feeds are regulated by the CFIA under the Feeds Act and the Feeds Regulations. In March 2024, Canada granted its first marketing authorisation for algal oil in salmonid feed.
Europe
Regulation (EC) No 767/2009 on the placing on the market and use of feed.
Regulation (EU) No 68/2013 on the Catalogue of feed materials, which includes entries for algae and algae-derived products.
Regulation (EC) No 1831/2003 on additives for use in animal nutrition, under which feed additives are assessed by EFSA's FEEDAP Panel before authorisation.
Directive 2002/32/EC on undesirable substances in animal feed, which sets maximum levels for contaminants such as arsenic in seaweed-derived feed materials.
Regulation (EC) No 183/2005 laying down requirements for feed hygiene.
Regulation (EU) 2019/6 on veterinary medicinal products, which restricts antimicrobial use in animals.
Asia Pacific
China: Feed and feed additives are regulated under the Regulations on the Administration of Feeds and Feed Additives, with permitted ingredients listed in the Catalogue of Feed Materials and the Catalogue of Feed Additives issued by the Ministry of Agriculture and Rural Affairs (MARA). Imported feed products require registration with the General Administration of Customs (GACC).
Japan: Feeds are regulated by the Ministry of Agriculture, Forestry and Fisheries (MAFF) under the Act on Safety Assurance and Quality Improvement of Feeds.
India: Bureau of Indian Standards (BIS) specifications apply to compounded feeds, and coastal aquaculture is regulated by the Coastal Aquaculture Authority under the Coastal Aquaculture Authority Act, 2005.
Latin America
Brazil: Animal feed products are regulated by the Ministry of Agriculture and Livestock (MAPA) under Law No. 6,198/1974 and Decree No. 6,296/2007, which require registration of feed establishments and products.
Middle East & Africa
Saudi Arabia: The Saudi Food and Drug Authority (SFDA) regulates animal feed products and their registration.
South Africa: Farm feeds are regulated under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act No. 36 of 1947).
Jun 2022: Veramaris; Strategy; Announced its transition from start-up to scale-up phase and appointed a new CEO effective October 2022.
Jun 2022: Allmicroalgae; Research Funding; The MICROBOOST project, led by Allmicroalgae to develop microalgae-based health boosters for aquafeeds, was approved under the EEA Grants programme.
Sep 2022: Acadian Seaplants; Expansion; Agreed a contribution from the Atlantic Canada Opportunities Agency to acquire automated processing equipment and expand its Cornwallis facility in Nova Scotia.
May 2023: Alltech; Acquisition; Acquired a majority stake in Agolin, a Swiss producer of plant-based feed additives for ruminants, including methane reduction applications.
Jul 2023: Olmix Group; Acquisition; Acquired Brazilian biotech company Yes Sinergy to expand in Latin America and pet care.
Aug 2023: CH4 Global; Funding; Closed a USD 29 million Series B round led by DCVC, DCVC Bio and Cleveland Avenue.
Sep 2023: CH4 Global; Partnership; Signed an agreement with Lotte International to commercialise its methane-reducing supplement for livestock farmers in South Korea.
Sep 2023: Corbion; Product Launch; Launched AlgaPrime DHA P3, a microalgae powder containing 35% DHA, for pet food.
Jan 2024: CH4 Global; Commercialisation; Made the first commercial delivery of Methane Tamer to a feedlot in South Australia.
Feb 2024: dsm-firmenich; Strategy; Announced its intention to separate the Animal Nutrition & Health business, retaining Veramaris.
Mar 2024: Veramaris; Regulatory Approval; Received Canada's first marketing authorisation for algal oil in salmonid feed.
May 2024: Veramaris; Partnership; Cermaq Canada began using Veramaris algal oil in Cargill salmon feed at its British Columbia farms.
Nov 2024: CH4 Global; Partnership; Signed a multi-year agreement with UPL to distribute Methane Tamer in India, Brazil, Argentina, Uruguay and Paraguay.
Nov 2024: Olmix Group; Partnership; Announced a cooperation with Pulte GmbH to launch algae-based animal nutrition products in Germany and Austria.
Jan 2025: CH4 Global; Partnership; Formed a strategic partnership with Mitsubishi Corporation covering Australian sales, regulatory validation in Japan and production feasibility in Southeast Asia.
Jan 2025: CH4 Global; Expansion; Opened Phase 1 of its Louth Bay EcoPark in South Australia, with capacity of about 80 tonnes of Asparagopsis per year.
Jul 2025: Corbion; Regulatory Approval; Received registrations from China's General Administration of Customs for AlgaPrime DHA and AlgaVia DHA.
Aug 2025: Corbion; Partnership; Signed a collaboration with Kuehnle AgroSystems to develop natural astaxanthin from algae fermentation for aquaculture and nutraceuticals.
Sep 2025: Veramaris; Expansion; Partnered with Merwetank to establish bulk algal oil storage in Dordrecht, the Netherlands, for European aquafeed producers.
Sep 2025: Alltech; Joint Venture; Announced a North American feed joint venture with ADM, launched as Akralos Animal Nutrition in February 2026.
Feb 2026: dsm-firmenich; Divestment; Agreed to sell its Animal Nutrition & Health business to CVC Capital Partners at an enterprise value of about EUR 2.2 billion, retaining Veramaris.
Feb 2026: Corbion; Expansion; Announced an investment decision to debottleneck its existing facility for additional omega-3 DHA oil capacity.
Apr 2026: dsm-firmenich / Veramaris; Product Launch; Launched Veramaris O3 Max Pure, a microalgal oil with a 3:2 EPA:DHA ratio, for pet food.
Apr 2026: Corbion; Patent; Was granted a U.S. patent covering a liquid suspension of lysed algal biomass in oil, the technology used in AlgaPrime DHA LS.
Aug 2026: Olmix Group / EW Group; Acquisition; EW Group completed the acquisition of Olmix Group, which continues as a standalone company.
Political
Government support for aquaculture and seaweed cultivation, including the EU Algae Initiative and India's PMMSY.
Food security strategies in import-dependent countries, such as the GCC states, encourage domestic aquaculture and feed production.
Trade policies and tariffs affect cross-border trade in feed ingredients.
Economic
Fish oil and fishmeal prices determine the relative competitiveness of algal omega-3 ingredients.
Feed accounts for a large share of livestock and aquaculture production costs, which makes buyers price sensitive.
Investment in fermentation and cultivation capacity depends on access to capital and long-term supply contracts.
Social
Rising consumption of seafood and animal protein in emerging economies supports feed demand.
Consumers increasingly prefer sustainably produced and antibiotic-free animal products.
Interest in omega-3 content of farmed fish supports the use of algal oils.
Technological
Advances in strain development and fermentation efficiency reduce production costs.
Land-based cultivation systems for seaweed, such as pond-based Asparagopsis production, improve supply control.
New product formats, such as stabilised biomass suspensions, simplify inclusion in feed.
Environmental
Algae-based ingredients reduce pressure on wild forage fish stocks.
Red seaweed supplements can reduce enteric methane emissions from ruminants.
Climate events, such as El Niño, affect marine ingredient supply and seaweed harvests.
Legal
Feed ingredient approvals are required in each market, and requirements differ by jurisdiction.
Maximum limits for contaminants such as arsenic and iodine apply to seaweed-based feed materials.
Patents on strains and processes, such as Corbion's U.S. patent for algal biomass suspension granted in 2026, protect producer technologies.
Profiles of 104 companies operating in the Algae-Based Feed Ingredients Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
3 interactive charts drawn from the Algae-Based Feed Ingredients Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Algae-Based Feed Ingredients Market By Livestock
Global Algae-Based Feed Ingredients Market By Product Type
Global Algae-Based Feed Ingredients Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
